Thyroid – Follicular & Papillary Cancer

Thyroid – Follicular & Papillary Cancer

Standard screening test: NONE Thyroid examination can be used for early detection. Not shown to reduce mortality, unable to detect tiny tumours. Thyroid cancer has the most rapidly increasing incidence among all major cancers, both in Canada and worldwide. In Canada,...
Testicular – Germ Cell Cancer

Testicular – Germ Cell Cancer

Standard screening test: NONE Examination can be used for early detection. Not shown to reduce mortality, unable to detect tiny tumours. • An estimated 1050 new cases occur in Canada per year. Known risk factors: • history of cryptorchidism • family history of...

Sarcoma

Standard screening test: NONE Known risk factors A history of cancer treatment with radiation therapy. Certain genetic disorders including: retinoblastoma (occurring mostly in children, caused by a mutation in the RB1 gene), Werner syndrome (caused by a mutation in...

Prostate Cancer

Standard screening test: rectal examination (can only detect posterior tumours), PSA (commonly used, but controversial since it has not been shown to reduce mortality. PSA is limited by false positives e.g. infection). Prostate cancer is the third most common cause of...

Pancreatic Cancer

Standard screening test: NONE Incidence is estimated to increase for pancreas and kidney cancer. Increases may be driven by changes in the prevalence of or exposure to risk factors and/or changes in diagnostic practices. Smoking, excess weight, physical inactivity,...

Ovarian Cancer

Standard screening test: NONE Pelvic ultrasound and CA125 can be used, but have not been shown to reduce mortality. Limited sensitivity and specificity. Known risk factors Family history of ovarian cancer. BRCA gene mutations, Lynch syndrome, nulliparity. Family...

Oropharyngeal – Squamous Cell Cancer

Standard screening test: Oral examination Mortality rates for cancers of oral cavity and pharynx have declined by 2.4% per year for males between 2001 and 2010. Mortality rates in females are stable between 2001 and 2010. The age-standardized mortality rate has fallen...

Myeloma

Standard screening test: NONE An estimated 2700 new cases of myeloma were diagnosed in Canada in 2015. The number of new cases in 2028–2032 are projected to be highest in the four major cancer types – prostate, lung, colorectal and breast. However, aside from prostate...